Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F OLIVER

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
British Medical Journal|August 25, 1973
Oral contraceptives and myocardial infarctionD J Radford, M F Oliver
Lancet (London, England)|October 1, 1977
Combined electrophysiological technique for assessment of the cellular basis of early ventricular arrhythmiasD C Russell, M F Oliver, J Wojtczak
International Journal of Epidemiology|June 1, 1989
Blood pressure, cigarette smoking and heart attack in the WHO co-operative trial of clofibrateK G Green, A Heady, M F Oliver
Lancet (London, England)|October 4, 1980
Haemodynamic effects of sulphinpyrazone on exercise responses in normal subjectsJ C Forfar, D C Russell, M F Oliver
Clinical and Experimental Pharmacology & Physiology|September 1, 1979
Electrophysiological and haemodynamic effects of a new inotropic agent (UK14275) in the dogD C Russell, H J Smith, M F Oliver
Lancet (London, England)|February 8, 1975
Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic-acid analogueM J Rowe, J M Neilson, M F Oliver
British Heart Journal|May 1, 1978
Regional variations in mortality from ischaemic heart and cerebrovascular disease in BritainM Fulton, W Adams, W Lutz, et al.
British Medical Journal|April 11, 1970
Clofibrate, serum enzymes, and muscle painA F Smith, W G Macfie, M F Oliver
British Medical Journal|September 30, 1978
Lack of relation between venous plasma total catecholamine concentrations and ventricular arrhythmias after acute myocardial infarctionR C Strange, M J Rowe, M F Oliver
Atherosclerosis|December 1, 1989
Effects of Maxepa on serum lipids in hypercholesterolaemic subjectsA M Dart, R A Riemersma, M F Oliver
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
British Medical Journal|August 25, 1973
Oral contraceptives and myocardial infarctionD J Radford, M F Oliver
Lancet (London, England)|October 1, 1977
Combined electrophysiological technique for assessment of the cellular basis of early ventricular arrhythmiasD C Russell, M F Oliver, J Wojtczak
International Journal of Epidemiology|June 1, 1989
Blood pressure, cigarette smoking and heart attack in the WHO co-operative trial of clofibrateK G Green, A Heady, M F Oliver
Lancet (London, England)|October 4, 1980
Haemodynamic effects of sulphinpyrazone on exercise responses in normal subjectsJ C Forfar, D C Russell, M F Oliver
Clinical and Experimental Pharmacology & Physiology|September 1, 1979
Electrophysiological and haemodynamic effects of a new inotropic agent (UK14275) in the dogD C Russell, H J Smith, M F Oliver
Lancet (London, England)|February 8, 1975
Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic-acid analogueM J Rowe, J M Neilson, M F Oliver
British Heart Journal|May 1, 1978
Regional variations in mortality from ischaemic heart and cerebrovascular disease in BritainM Fulton, W Adams, W Lutz, et al.
British Medical Journal|April 11, 1970
Clofibrate, serum enzymes, and muscle painA F Smith, W G Macfie, M F Oliver
British Medical Journal|September 30, 1978
Lack of relation between venous plasma total catecholamine concentrations and ventricular arrhythmias after acute myocardial infarctionR C Strange, M J Rowe, M F Oliver
Atherosclerosis|December 1, 1989
Effects of Maxepa on serum lipids in hypercholesterolaemic subjectsA M Dart, R A Riemersma, M F Oliver
Pageof 9